Генетическая карта здоровья (стр. 6 )

57.        Yamada, N., et al., The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia. J Hum Genet, 2000. 45(3): p. 138-41.

58.        Cho, S. H., C. H. Ryu, and C. K. Oh, Plasminogen activator inhibitor-1 in the pathogenesis of asthma. Exp Biol Med (Maywood), 2004. 229(2): p. 138-46.

59.        Buckova, D., L. Izakovicova Holla, and J. Vacha, Polymorphism 4G/5G in the plasminogen activator inhibitor-1 (PAI-1) gene is associated with IgE-mediated allergic diseases and asthma in the Czech population. Allergy, 2002. 57(5): p. 446-8.

60.        Kowal, K., et al., Analysis of -675 4G/5G SERPINE1 and C-159T CD14 polymorphisms in house dust mite-allergic asthma patients. J Investig Allergol Clin Immunol, 2008. 18(4): p. 284-92.

61.        Kishimoto, T., The biology of interleukin-6. Blood, 1989. 74(1): p. 1-10.

62.        Kita, M., et al., Induction of cytokines in human peripheral blood mononuclear cells by mycoplasmas. Microbiol Immunol, 1992. 36(5): p. 507-16.

63.        Mysliwska, J., et al., The -174GG interleukin-6 genotype is protective from retinopathy and nephropathy in juvenile onset type 1 diabetes mellitus. Pediatr Res, 2009. 66(3): p. 341-5.

64.        Tischendorf, J. J., et al., The interleukin-6 (IL6)-174 G/C promoter genotype is associated with the presence of septic shock and the ex vivo secretion of IL6. Int J Immunogenet, 2007. 34(6): p. 413-8.

65.        Antonicelli, R., et al., The interleukin-6 -174 G>C promoter polymorphism is associated with a higher risk of death after an acute coronary syndrome in male elderly patients. Int J Cardiol, 2005. 103(3): p. 266-71.

66.        Balding, J., et al., The IL-6 G-174C polymorphism may be associated with ischaemic stroke in patients without a history of hypertension. Ir J Med Sci, 2004. 173(4): p. 200-3.

67.        Kamarainen, O. P., et al., Common interleukin-6 promoter variants associate with the more severe forms of distal interphalangeal osteoarthritis. Arthritis Res Ther, 2008. 10(1): p. R21.

68.        Settin, A., et al., Gene polymorphisms of IL-6(-174) G/C and IL-1Ra VNTR in asthmatic children. Indian J Pediatr, 2008. 75(10): p. 1019-23.

69.        Naski, M. C., L. Lorand, and J. A. Shafer, Characterization of the kinetic pathway for fibrin promotion of alpha-thrombin-catalyzed activation of plasma factor XIII. Biochemistry, 1991. 30(4): p. 934-41.

70.        Lorand, L., Sol Sherry Lecture in Thrombosis : research on clot stabilization provides clues for improving thrombolytic therapies. Arterioscler Thromb Vasc Biol, 2000. 20(1): p. 2-9.

71.        Sakata, Y. and N. Aoki, Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. J Clin Invest, 1982. 69(3): p. 536-42.

72.        Iwaki, T., et al., Fibrinogen stabilizes placental-maternal attachment during embryonic development in the mouse. Am J Pathol, 2002. 160(3): p. 1021-34.

73.        Asahina, T., et al., Studies on the role of adhesive proteins in maintaining pregnancy. Horm Res, 1998. 50 Suppl 2: p. 37-45.

74.        Ariens, R. A., et al., The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood, 2000. 96(3): p. 988-95.

75.        Bereczky, Z., et al., Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease. Thromb Res, 2008. 121(4): p. 469-76.

76.        Hsieh, L. and D. Nugent, Factor XIII deficiency. Haemophilia, 2008. 14(6): p. 1190-200.

77.        Koseki-Kuno, S., et al., Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages. Blood, 2003. 102(13): p. 4410-2.

78.        Castaman, G., Prophylaxis of bleeding episodes and surgical interventions in patients with rare inherited coagulation disorders. Blood Transfus, 2008. 6 Suppl 2: p. s39-44.

79.        Dargaud, Y., et al., An unusual clinical presentation of factor XIII deficiency and issues relating to the monitoring of factor XIII replacement therapy. Blood Coagul Fibrinolysis, 2008. 19(5): p. 447-52.

80.        Inbal, A. and L. Muszbek, Coagulation factor deficiencies and pregnancy loss. Semin Thromb Hemost, 2003. 29(2): p. 171-4.

81.        Renner, W., et al., Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: common mutations of blood coagulation factors and deep vein thrombosis in Austria. Thromb Res, 2000. 99(1): p. 35-9.

82.        Gohil, R., G. Peck, and P. Sharma, The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls. Thromb Haemost, 2009. 102(2): p. 360-70.

83.        Coulam, C. B., et al., Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis. Am J Reprod Immunol, 2008. 60(5): p. 426-31.

84.        de la Red, G., et al., Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels. Thromb Haemost, 2009. 101(2): p. 312-6.

85.        Mutch, N. J., et al., Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis. J Thromb Haemost, 2010.

86.        Anwar, R. and K. J. Miloszewski, Factor XIII deficiency. Br J Haematol, 1999. 107(3): p. 468-84.

87.        Ladenvall, C., et al., Association between factor XIII single nucleotide polymorphisms and aneurysmal subarachnoid hemorrhage. J Neurosurg, 2009. 110(3): p. 475-81.

88.        Rodeghiero, F., et al., Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitutive therapy. Report of a second case. Blut, 1987. 55(1): p. 45-8.

89.        Cushman, M., The role of imflammation in Cardiovascular disease and effect of hormon replasment, in Материалы V международного симпозиума по проблемам здоровья женщин и менопаузе. 2004: Италия.

90.        Макацария, А. Д., , and , Профилактика и лечение тромбоэмболических осложнений в акушерстве, in Тромбозы и тромбоэмболии в акушерско-гинекологической клинике. 2007, Медицинское информационное агенство: М. p. 1064.